David K. Morris Sells 68,547 Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) insider David K. Morris sold 68,547 shares of Guardian Pharmacy Services stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total value of $1,381,907.52. Following the transaction, the insider now directly owns 214,495 shares in the company, valued at approximately $4,324,219.20. The trade was a 24.22% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Guardian Pharmacy Services Price Performance

Shares of GRDN traded down $0.10 during midday trading on Friday, reaching $21.29. The stock had a trading volume of 481,223 shares, compared to its average volume of 168,263. The company's 50-day moving average is $23.16 and its 200 day moving average is $22.00. Guardian Pharmacy Services, Inc. has a 12-month low of $14.16 and a 12-month high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.01). The company had revenue of $329.31 million during the quarter, compared to analyst estimates of $321.21 million. Equities analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have weighed in on GRDN shares. Truist Financial reissued a "buy" rating and issued a $28.00 price objective (up previously from $25.00) on shares of Guardian Pharmacy Services in a research report on Monday, May 19th. Wall Street Zen lowered Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Raymond James set a $28.00 target price on Guardian Pharmacy Services and gave the stock an "outperform" rating in a research note on Wednesday, May 14th.

Institutional Trading of Guardian Pharmacy Services

A number of institutional investors and hedge funds have recently modified their holdings of GRDN. GAMMA Investing LLC bought a new stake in shares of Guardian Pharmacy Services in the first quarter worth $170,000. R Squared Ltd purchased a new position in shares of Guardian Pharmacy Services in the fourth quarter valued at about $30,000. BNP Paribas Financial Markets purchased a new position in shares of Guardian Pharmacy Services in the fourth quarter valued at about $37,000. Compass Financial Services Inc purchased a new position in shares of Guardian Pharmacy Services in the fourth quarter valued at about $58,000. Finally, JPMorgan Chase & Co. purchased a new stake in shares of Guardian Pharmacy Services in the fourth quarter worth about $77,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.